Cardinal Health, Inc. $CAH Holdings Trimmed by Arkfeld Wealth Strategies L.L.C.

Arkfeld Wealth Strategies L.L.C. cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 12.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,650 shares of the company’s stock after selling 392 shares during the quarter. Arkfeld Wealth Strategies L.L.C.’s holdings in Cardinal Health were worth $444,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Greykasell Wealth Strategies Inc. bought a new stake in Cardinal Health during the first quarter worth approximately $26,000. Jones Financial Companies Lllp boosted its stake in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares in the last quarter. Tompkins Financial Corp grew its holdings in shares of Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock worth $34,000 after acquiring an additional 128 shares during the last quarter. GW&K Investment Management LLC raised its position in shares of Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares during the period. Finally, NBC Securities Inc. acquired a new stake in shares of Cardinal Health during the first quarter worth $48,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Cardinal Health stock opened at $150.04 on Friday. Cardinal Health, Inc. has a twelve month low of $106.54 and a twelve month high of $168.44. The firm has a market cap of $35.65 billion, a PE ratio of 23.26, a P/E/G ratio of 1.26 and a beta of 0.73. The firm’s 50 day moving average price is $153.29 and its two-hundred day moving average price is $148.23.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. During the same period in the previous year, the company posted $1.84 EPS. Cardinal Health’s revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health’s payout ratio is 31.63%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Citigroup reissued a “neutral” rating and issued a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Argus set a $189.00 target price on shares of Cardinal Health in a report on Friday, August 22nd. UBS Group restated a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Leerink Partners decreased their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an “outperform” rating for the company in a research note on Tuesday, August 12th. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $165.93.

Insider Buying and Selling

In other news, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jason M. Hollar sold 107,705 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total value of $16,037,274.50. Following the completion of the sale, the chief executive officer directly owned 235,901 shares of the company’s stock, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 271,676 shares of company stock worth $40,489,525. Insiders own 0.09% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.